Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti, Marcella 1,+; Sala, Luca 1,+; Rizzetto, Riccardo 1; Staszewsky, Lidia Irene 2; Alemanni, Matteo 1; Zambelli, Vanessa 3; Russo, Ilaria 2; Barile, Lucio 4; Cornaghi, Laura 5; Altomare, Claudia 1; Ronchi, Carlotta 1; Mostacciuolo, Gaspare 1; Lucchetti, Jacopo 6; Gobbi, Marco 6; Latini, Roberto 2; Zaza, Antonio 1,*
[Article] Cardiovascular Research. 104(1):37-48, October 01, 2014.

(Format: HTML, PDF)